$68.84 0.90 (+1.33%)
2/13/2012 12:28 PM

Medivation, Inc. (NASDAQ:MDVN)

CAPS Rating: 1 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Featured Broker Partners


Advertisement